Blog

History of Chief Complaint: Mr. P is a 61-year-old who colla…

History of Chief Complaint: Mr. P is a 61-year-old who collapsed at work and was transported to the ER by ambulance where 12 Lead ECG showed ST elevations in leads II, III, with reciprocal changes anteriorly, indicating inferior wall ischemia.  He was given nitroglycerin which resulted in partial, but not complete resolution of the chest pain. He subsequently had a cardiac catheterization which showed a RCA occlusion and a stent was placed in his RCA, resulting in gradual resolution of the chest pain. An echocardiogram was performed during his admission which showed an Ejection fraction of 40-45% with inferior wall hypokinesis.  Pt was discharged home with orders to have PFT’s and Cardiac Rehabilitation. 6 weeks post the myocardial infarction, patient underwent a Bruce Protocol stress test in preparation for enrolling in cardiac rehab and PFT’s.  He presents to Outpatient Cardiac Rehab for evaluation . PMH: occasional gastric reflux Medications:  Metoprolol succinate, Ticagrelor, Valsartan, Rosuvastatin, zantac as needed, Nitroglycerin sublingual and aspirin. Social History/Habits: Married, lives in 2nd floor apartment. Works fulltime in Buildings and Grounds at local University.  Has 2 adult sons who live out of state.  Heavy smoker of 3ppd x 35 years, quitting 6 weeks ago. Reports 5-6 glasses of wine/week.  No regular form of exercise outside of work. Since discharge from Acute Care, pt has been walking at a fairly light level of exertion for 20 minutes. Ht: 5’9”   Wt 175   BMI 25.8 Labs: WBC 6.0   RBC 3.60   Hgb 12.1   HCT 34.6   BUN 33    Cr 1.3 PFTs: FVC= 80% predicted FEV1 = 58% predicted FEV1/FVC% = 68%   Exercise Stress Test: Bruce protocol Baseline EKG strip @ rest was NSR (see below) The patient developed isolated PVC’s during the latter part of exercise beginning at a HR of 110, but without repetitive forms.  PVC’s continued during the post exercise period with occasional PAC’s, again without repetitive forms.    Beginning at HR of 117 bpm, EKG changes began to develop with ST depression reaching 3 mm in the inferior leads at the end of the test.                                                                              HR                   BP Rest:                                                                      76                     142/78 ECG changes (5 mins, Stage 2):                          117                   180/80 Peak (6 mins, Stage 2):                                         130                   180/88   Pt completed 6 minutes (~7 METS), stopping because of developing substernal chest pressure and fullness in throat (anginal equivalent similar to MI presentation). He was given nitroglycerin and his chest pressure and full throat disappeared.  Limited cardiac exam post test was unremarkable. Echocardiogram (performed during admission) The left ventricle is normal in size.  Concentric remodeling (increased relative wall thickness and normal LV mass index).  Ejection Fraction = 40-45%;  Inferior Hypokinesis. No diastolic dysfunction parameters to suggest elevated left atrial pressure or congestive heart failure.  right ventricular systolic function is normal. No significant valvular disease. Tests and Measures: Resting Vitals: HR 72, RR 20, BP 146/76, RA SpO2 97%   Practical Examination: Patient is arriving at Phase 2 Outpatient Cardiac Rehabilitation, this is his first session, proceed with your evaluation/assessment/interventions/education. I have read the above case and am prepared for the practical exam:       

Roberto Corporation was organized on January 1, 2024. The fi…

Roberto Corporation was organized on January 1, 2024. The firm was authorized to issue 84,000 shares of $5 par common stock. During 2024, Roberto had the following transactions relating to shareholders’ equity: Issued 9.500 shares of common stock at $7.10 per share. Issued 2,000 shares of common stock at $10.00 per share. Reported NI of $102,000. Paid dividends of $59,000. Purchased 3,600 shares of treasury stock at $12.00. What are the balances, in dollars, in each of the following accounts: Common stock: [BLANK-1] APIC-C/S: [BLANK-2] Treasury stock: [BLANK-3] Retained earnings: [BLANK-4] Total Shareholders’ Equity at the end of 2024: [BLANK-5]

Equipment was purchased at the beginning of 2016 for $740,00…

Equipment was purchased at the beginning of 2016 for $740,000. At the time of its purchase, the equipment was estimated to have a useful life of 6 years and a salvage value of $89,000. The equipment was depreciated using the straight-line method of depreciation through 2018. At the beginning of 2019, the estimate of useful life was revised to a total life of 8 years and the expected salvage value was changed to $57,000. The amount to be recorded for depreciation for 2019, reflecting these changes in estimates is

(Show ALL your work and round all numbers to the nearest dol…

(Show ALL your work and round all numbers to the nearest dollar).  Agler Corporation’s beginning of year balance sheet reported the following:               Common stock (10,000 shares issued & outstanding, $5 par)              $  50,000               Paid-in capital in excess of par (APIC-C/S)                                             160,000               Retained earnings                                                                                   100,000  The following transactions occurred this year:            February 1: Purchased 500 shares of capital stock to be held as treasury stock, paying $45 per share.            May 1: Reissued 200 of the shares of treasury stock at $48 per share.            September 1: Reissued 100 shares of treasury stock at $23 per share.            December 1: Announced a 2-for-1 split, effective December 1. Required:  1.Prepare the journal entries for each transaction under the cost method of accounting for treasury stock.           2/1: dr. [BLANK-1] for [BLANK-2]                  cr. [BLANK-3] for [BLANK-4]           5/1: dr. [BLANK-5] for [BLANK-6]                   cr. [BLANK-7] for [BLANK-8]                   cr. [BLANK-9] for [BLANK-10]           9/1: dr. [BLANK-11] for [BLANK-12]                   dr. [BLANK-13] for[BLANK-14]                   dr. [BLANK-15] for [BLANK-16]                   cr. [BLANK-17] for [BLANK-18]            12/1: [BLANK-19] 2.At end of year, what is the Number of shares of common stock outstanding is [BLANK-20] shares Par value per common stock is [BLANK-21] per share. Remaining balance ($) in Treasury stock is [BLANK-22]